Clin2
NCT06746831Possibly a fitNot yet recruiting

Effects of methamphetamine forms in healthy volunteers

Methamphetamine

Part of Mental health clinical trials.

This study compares how the two different forms (isomers) of methamphetamine work in the body. It is a phase 1 trial with healthy volunteers, aimed at understanding how the drug is processed and its effects.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
17 people
Ages
21 years to 64 years
Study type
Interventional

Who can take part

  • You must be in good overall health

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06721494Recruiting· Phase 2
A single-dose study of CS-1103 for methamphetamine use

This trial tests a single dose of an investigational drug, CS-1103, to see if it is safe and effective for people who use methamphetamine. It may help understand how the drug affects methamphetamine in the body.

Glendale, California
NCT07584369Not yet recruiting· Phase 4
Effects of methamphetamine on hidden HIV

This study looks at how a single dose of methamphetamine affects the hidden HIV that stays in the body even when the virus is undetectable. It may help researchers understand how to better treat or cure HIV in the future.

San Francisco, California
NCT07086014Recruiting
Brain response to methamphetamine cues in men

This study uses brain scans to see how men with methamphetamine use disorder react to images or reminders of the drug. It aims to understand cravings and brain activity, which could help improve treatments.

New York, New York
NCT07459244Recruiting
ECG changes in people who use methamphetamine

This study looks at the electrical activity of the heart (ECG) in people who use methamphetamine, including those who develop psychosis from it. It compares them to healthy volunteers to see if methamphetamine affects heart function.

Elâzığ, Elâzığ
NCT05854667Recruiting· Phase 2
High-dose lisdexamfetamine with rewards for meth use changes

This Phase 2 study tests high-dose lisdexamfetamine (a prescription stimulant) to help people reduce or stop methamphetamine use. It also uses “contingency management” (rewards tied to meeting goals) to encourage treatment participation and lower use.

Vancouver, British Columbia
NCT07774702Not yet recruiting· Phase 2
Psilocybin for methamphetamine use disorder

This trial tests whether psilocybin, a psychedelic substance, can help people with moderate to severe methamphetamine use disorder reduce or stop their use. It may work by helping the brain reset, but it's not a standard treatment and involves careful monitoring.

Birmingham, Alabama

Hear when a new Methamphetamine trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.